0001567619-19-019762.txt : 20191018
0001567619-19-019762.hdr.sgml : 20191018
20191018170922
ACCESSION NUMBER: 0001567619-19-019762
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20191018
DATE AS OF CHANGE: 20191018
EFFECTIVENESS DATE: 20191018
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Icosavax, Inc.
CENTRAL INDEX KEY: 0001786255
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-351428
FILM NUMBER: 191158375
BUSINESS ADDRESS:
STREET 1: 2815 EASTLAKE AVE E, SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: (206) 336-5600
MAIL ADDRESS:
STREET 1: 2815 EASTLAKE AVE E, SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98102
D
1
primary_doc.xml
X0708
D
LIVE
0001786255
Icosavax, Inc.
2815 Eastlake Ave E, Suite 300
Seattle
WA
WASHINGTON
98102
(206) 336-5600
DELAWARE
None
None
Corporation
true
2017
Tadataka
Yamada, M.D.
2815 Eastlake Ave E, Suite 300
Seattle
WA
WASHINGTON
98102
Director
Chairman of the Board
Adam
K.
Simpson
2815 Eastlake Ave E, Suite 300
Seattle
WA
WASHINGTON
98102
Executive Officer
Director
President and Chief Executive Officer
Douglas
A.
Holtzman
2815 Eastlake Ave E, Suite 300
Seattle
WA
WASHINGTON
98102
Executive Officer
Chief Scientific Officer, Treasurer and Secretary
Charles
Richardson
2815 Eastlake Ave E, Suite 300
Seattle
WA
WASHINGTON
98102
Executive Officer
Senior Vice President, Technical Operations
Mark
McDade
2815 Eastlake Ave E, Suite 300
Seattle
WA
WASHINGTON
98102
Director
Terry
Gould
2815 Eastlake Ave E, Suite 300
Seattle
WA
WASHINGTON
98102
Director
Jason
Hafler
2815 Eastlake Ave E, Suite 300
Seattle
WA
WASHINGTON
98102
Director
Eric
Moessinger
2815 Eastlake Ave E, Suite 300
Seattle
WA
WASHINGTON
98102
Director
Niranjan
Kanesa-thasan
2815 Eastlake Ave E, Suite 300
Seattle
WA
WASHINGTON
98102
Executive Officer
Chief Medical Officer
Biotechnology
Decline to Disclose
- 06b
false
2019-08-15
true
true
false
0
51007373
30007376
20999997
false
22
0
0
0
false
Icosavax, Inc.
/s/ Adam K. Simpson
Adam K.Simpson
President and Chief Executive Officer
2019-10-08